Watchlist Manager

Watchlist

Price: 8.25 CNY -1.55% Market Closed

Market Cap: ¥8.6B

	Shandong Lukang Pharmaceutical Co Ltd SSE:600789	CN

Balance Sheet

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	206	67	248	136	106	45	134	122	210	389	421	472	589	507	543	601	801	720	564	444	577	387	530	496
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	568	387	530	496
Cash Equivalents	206	67	248	136	106	45	134	122	210	389	421	472	589	507	543	601	801	720	563	444	9	0	0	0
Short-Term Investments	0	0	0	0	0	0	0	0	1	2	1	1	10	2	3	2	2	1	1	1	1	1	1	1
Total Receivables	392	419	361	388	414	461	415	338	393	495	544	714	749	809	764	636	621	768	777	907	887	1 261	1 390	1 819
Accounts Receivables	299	276	270	303	321	354	240	266	264	266	311	395	389	401	439	448	428	514	480	549	576	689	802	940
Other Receivables	93	143	91	85	93	107	175	72	128	228	232	320	360	407	325	188	193	254	297	358	311	571	588	878
Inventory	204	185	267	272	252	218	381	446	362	475	519	548	467	484	508	558	728	847	864	869	1 208	1 481	1 406	1 484
Other Current Assets	25	15	27	37	26	23	39	29	27	128	145	71	58	49	36	32	37	598	379	286	79	379	321	330
Total Current Assets	827	685	903	832	798	747	968	935	993	1 488	1 629	1 807	1 873	1 850	1 852	1 828	2 189	2 934	2 585	2 507	2 751	3 509	3 648	4 130
PP&E Net	1 519	1 646	1 707	1 716	1 625	1 525	1 412	1 363	1 271	1 319	1 641	1 861	1 753	1 738	1 828	1 801	2 348	2 698	3 244	3 750	3 921	4 047	3 887	3 833
PP&E Gross	1 519	1 646	1 707	1 716	1 625	1 525	1 412	1 363	1 271	1 319	1 641	1 861	1 753	1 738	1 828	1 801	2 348	2 698	3 244	3 750	3 921	4 047	3 887	3 833
Accumulated Depreciation	301	390	482	605	736	866	1 015	1 183	1 225	1 359	1 441	1 615	1 753	1 751	1 685	1 789	1 886	1 268	908	1 020	1 307	1 620	1 955	2 326
Intangible Assets	10	14	18	48	57	51	59	61	58	60	115	211	232	228	218	212	251	289	540	574	736	749	831	893
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	23	47	256	447	124	135	144	172	0
Long-Term Investments	49	49	69	102	107	106	138	137	152	154	93	100	115	134	100	95	97	71	73	181	133	158	157	130
Other Long-Term Assets	0	0	0	0	0	0	4	5	5	4	3	7	178	135	17	219	270	319	200	137	146	121	107	112
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	2 405 N/A	2 394 0%	2 697 +13%	2 698 +0%	2 585 -4%	2 429 -6%	2 582 +6%	2 501 -3%	2 478 -1%	3 025 +22%	3 481 +15%	3 985 +14%	4 151 +4%	4 085 -2%	4 018 -2%	4 178 +4%	5 202 +25%	6 567 +26%	7 089 +8%	7 273 +3%	7 822 +8%	8 728 +12%	8 802 +1%	9 098 +3%
Liabilities
Accounts Payable	203	252	273	294	329	308	279	275	267	317	459	647	636	569	392	493	541	644	715	768	796	1 611	1 503	1 503
Accrued Liabilities	15	16	20	25	22	43	42	41	38	38	39	10	55	48	49	25	36	36	33	47	54	98	266	421
Short-Term Debt	189	131	240	358	345	422	513	467	439	856	1 014	1 044	851	734	519	824	867	1 155	1 670	2 005	1 688	1 388	954	570
Current Portion of Long-Term Debt	136	126	133	152	181	140	85	90	24	7	8	48	73	217	310	11	36	188	545	45	673	622	453	281
Other Current Liabilities	137	180	97	143	110	48	100	107	122	98	80	91	145	327	275	251	242	252	237	262	267	411	341	286
Total Current Liabilities	681	705	764	973	987	961	1 018	979	890	1 315	1 600	1 820	1 760	1 894	1 543	1 603	1 723	2 274	3 201	3 127	3 478	4 129	3 517	3 061
Long-Term Debt	538	431	318	230	100	45	55	21	38	31	23	375	518	303	285	431	1 170	937	203	577	693	867	1 309	1 686
Minority Interest	0	0	0	0	0	1	13	21	24	28	31	88	107	95	95	127	141	144	151	145	145	150	130	143
Other Liabilities	25	1	0	0	0	1	6	0	2	2	165	183	237	384	285	162	210	284	514	210	223	224	235	290
Total Liabilities	1 243 N/A	1 136 -9%	1 082 -5%	1 203 +11%	1 087 -10%	1 007 -7%	1 092 +8%	1 021 -6%	954 -7%	1 377 +44%	1 819 +32%	2 467 +36%	2 623 +6%	2 676 +2%	2 208 -17%	2 323 +5%	3 244 +40%	3 640 +12%	4 068 +12%	4 059 0%	4 539 +12%	5 371 +18%	5 191 -3%	5 180 0%
Equity
Common Stock	365	365	412	412	412	582	582	582	582	582	582	582	582	582	582	582	582	677	880	880	881	887	896	899
Retained Earnings	261	357	370	253	258	161	183	218	256	385	400	255	266	141	149	178	281	422	514	703	755	849	1 047	1 344
Additional Paid In Capital	536	536	833	833	833	679	726	681	687	682	681	682	676	677	1 080	1 096	1 096	1 829	1 627	1 632	1 653	1 630	1 683	1 698
Unrealized Security Profit/Loss	0	0	0	3	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6	10	15	22
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	4	10	0	0	0	0	0	1	0	0	0	0
Total Equity	1 162 N/A	1 258 +8%	1 615 +28%	1 495 -7%	1 498 +0%	1 421 -5%	1 490 +5%	1 480 -1%	1 524 +3%	1 649 +8%	1 663 +1%	1 519 -9%	1 528 +1%	1 409 -8%	1 810 +28%	1 855 +2%	1 958 +6%	2 927 +50%	3 021 +3%	3 214 +6%	3 283 +2%	3 357 +2%	3 612 +8%	3 918 +8%
Total Liabilities & Equity	2 405 N/A	2 394 0%	2 697 +13%	2 698 +0%	2 585 -4%	2 429 -6%	2 582 +6%	2 501 -3%	2 478 -1%	3 025 +22%	3 481 +15%	3 985 +14%	4 151 +4%	4 085 -2%	4 018 -2%	4 178 +4%	5 202 +25%	6 567 +26%	7 089 +8%	7 273 +3%	7 822 +8%	8 728 +12%	8 802 +1%	9 098 +3%
Shares Outstanding
Common Shares Outstanding	670	670	756	756	756	756	756	756	756	756	756	756	756	756	756	756	756	880	880	880	881	887	896	899

Income Statement Balance Sheet Cash Flow Statement

Shandong Lukang Pharmaceutical Co Ltd
SSE:600789

Balance Sheet

Balance Sheet Decomposition
Shandong Lukang Pharmaceutical Co Ltd

Balance Sheet
Shandong Lukang Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Shandong Lukang Pharmaceutical Co Ltd SSE:600789

Balance Sheet

Balance Sheet Decomposition Shandong Lukang Pharmaceutical Co Ltd

Balance Sheet Shandong Lukang Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Shandong Lukang Pharmaceutical Co Ltd
SSE:600789

Balance Sheet Decomposition
Shandong Lukang Pharmaceutical Co Ltd

Balance Sheet
Shandong Lukang Pharmaceutical Co Ltd